BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park J, Kim J, Kim S, Jung JH, Jang M, Park S, Lee M, Kim H, Suk KT, Kim DJ. Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics. Biomedicines 2022;10:1288. [DOI: 10.3390/biomedicines10061288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu S, Cao Y, Lu H, Qi X, Sun J, Ye Y, Gong L. Aberrant peribiliary gland niche exacerbates fibrosis in primary sclerosing cholangitis and a potential therapeutic strategy. Biomedicine & Pharmacotherapy 2022;153:113512. [DOI: 10.1016/j.biopha.2022.113512] [Reference Citation Analysis]
2 Shibahara I, Shibahara Y, Hagiwara H, Watanabe T, Orihashi Y, Handa H, Inukai M, Hide T, Yasui Y, Kumabe T. Ventricular opening and cerebrospinal fluid circulation accelerate the biodegradation process of carmustine wafers suggesting their immunomodulation potential in the human brain. J Neurooncol 2022. [PMID: 35802230 DOI: 10.1007/s11060-022-04078-5] [Reference Citation Analysis]